Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.38Price to Book
VS
Market
Sector
Industry
History
$ 15.67Close
$ 5.56 - $ 16.49 52-Week Range
Ticker Information
Ticker
IMNMCompany Name
IMMUNOME INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMUNOME INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IMNM - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 269.27M | $ 910.49M | 3.38 |
| 3/31/2025 | $ 307.13M | $ 690.88M | 2.25 |
| 12/31/2024 | $ 181.16M | $ 745.17M | 4.11 |
| 9/30/2024 | $ 214.91M | $ 723.41M | 3.37 |
| 6/30/2024 | $ 253.84M | $ 759.09M | 2.99 |
| 3/31/2024 | $ 285.57M | $ 882.74M | 3.09 |
| 12/31/2023 | $ 119.88M | $ 1.47B | 12.29 |
| 9/30/2023 | $ 6.08M | $ 365.77M | 60.2 |
| 6/30/2023 | $ 9.34M | $ 85.91M | 9.2 |
| 3/31/2023 | $ 13.86M | $ 65.96M | 4.76 |
Key Performance Insights, Last 5 Years
- IMMUNOME INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, IMMUNOME INC's average P/B has been 7.16.
- The median P/B for IMMUNOME INC during this period was 3.38
- IMMUNOME INC reached its highest P/B over the past 5 years at 60.2.
- The lowest P/B recorded by IMMUNOME INC in the same timeframe 0.81
IMMUNOME INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for IMMUNOME INC is calculated as follows: Market Cap [ $ 120.49M ] / Equity [ $ -49.09M ]
(=) P/B [ 0 ] IMNM - Price to Book, Last 5 years
0.81
Minimum
Mar 31, 2022
60.2
Maximum
Sep 30, 2023
7.16
Average
3.38
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |